1 |
The WHO Classification of Tumours of Editorial Board. WHO classification of soft tissue and bone tumours[M].5th ed. Lyon: IRAC Press, 2020: 1-335.
|
2 |
ANTONESCU C R, OWOSHO A A, ZHANG L, et al. Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases[J]. Am J Surg Pathol, 2017, 41(7): 941-949.
|
3 |
YOSHIMOTO T, TANAKA M, HOMME M, et al. CIC-DUX4 induces small round cell sarcomas distinct from ewing sarcoma[J]. Cancer Res, 2017, 77(11): 2927-2937.
|
4 |
DONAHUE J E, YAKIREVICH E, ZHONG S, et al. Primary spinal epidural CIC-DUX4 undifferentiated sarcoma in a child[J]. Pediatr Dev Pathol, 2018, 21(4): 411-417.
|
5 |
YAMADA Y, KUDA M, KOHASHI K, et al. Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes[J]. Virchows Arch, 2017, 470(4): 373-380.
|
6 |
OKIMOTO R A, WU W, NANJO S, et al. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs[J]. J Clin Invest, 2019, 129(8): 3401-3406.
|
7 |
MACHADO I, YOSHIDA A, MORALES M G N, et al. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis[J]. Ann Diagn Pathol, 2018, 34: 1-12.
|
8 |
MAGHREBI H, BATTI R, ZEHANI A, et al. Round cell sarcoma of the colon with CIC rearrangement[J]. BMC Res Notes, 2017, 10(1): 582.
|
9 |
WATSON S, PERRIN V, GUILLEMOT D, et al. Transcriptomic definition of molecular subgroups of small round cell sarcomas[J]. J Pathol, 2018, 245(1): 29-40.
|
10 |
LE LOARER F, PISSALOUX D, WATSON S, et al. Clinicopathologic features of CIC-NUTM1 sarcomas, a new molecular variant of the family of CIC-fused sarcomas[J]. Am J Surg Pathol, 2019, 43(2): 268-276.
|
11 |
YANG S, LIU L, YAN Y, et al. CIC‑NUTM1 sarcomas affecting the spine: a subset of CIC‑rearranged sarcomas commonly present in the axial skeleton[J]. Arch Pathol Lab Med, 2021.DOI: 10.5858/ARPA. 2021-0153-OA.
|
12 |
CHENG Y, HE C, WANG M N, et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials[J]. Signal Transduct Target Ther, 2019, 4: 62.
|
13 |
BOSNAKOVSKI D, ENER E T, COOPER M S, et al. Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma[J]. Oncogenesis, 2021, 10(10): 68.
|
14 |
YOSHIDA A, GOTO K, KODAIRA M, et al. CIC-rearranged sarcomas: a study of 20 cases and comparisons with ewing sarcomas[J]. Am J Surg Pathol, 2016, 40(3): 313-323.
|